CVS adds Eli Lilly's Zepbound to preferred drug list, reversing earlier exclusion. The pharmacy chain now covers the weight-loss drug for millions of members.
CVS Health has added Eli Lilly's weight-loss drug Zepbound to its preferred drug list, reversing its previous exclusion.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near US
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
France becomes first EU country to reimburse anti-obesity drugs, minister says
France becomes the first European Union country to reimburse anti-obesity drugs, according to a minister.
Suspected Ebola case in Austria as patient hospitalized with possible symptoms, Daily Mail reports.
A patient in Austria has been admitted to hospital with possible symptoms of Ebola, according to Daily Mail.
US annual inflation accelerates to highest since 2023 in April as Iran war drives up energy prices; consumer spending edges higher.
US consumer spending rose slightly in April, while annual inflation accelerated to its highest level since 2023, driven by rising energy prices amid the Iran war.
US durable goods orders surge 7.9% in April, handily beating 4.0% estimate and prior month's 0.8% rise.
US durable goods orders in April rose 7.9% month-over-month, well above the estimated 4.0% and the prior month's 0.8%.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.